Not Signed In - FDA Approves First Generic Bupropion Hydrochloride Extended-Release Tablets
Thu, 28 Dec 2006 08:00 AM EST
... The U. S. Food and Drug Administration (FDA) today approved the first generic version of Wellbutrin XL (Bupropion hydrochloride) Extended-Release Tablets, which are indicated for the treatment of major depressive disorder (MDD). The approval is an important step in the agency's effort to increase the availability of lower-cost generic medications. [click link for full article] ...
Related Topics
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Bupropion Extended-Release
- Bupropion SR
- Bupropion
- Niacin Extended Release
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Lovastatin Extended Release
- Isradipine Extended-Release Tablets
- Bupropion Sustained-Release (Zyban)
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Metformin Extended-Release
- Pseudoephedrine Extended Release
- Chlorpromazine Extended-Release Capsules
- Fexofenadine and Pseudoephedrine
- Carbinoxamine and Pseudoephedrine Tablets
- Desipramine
- Quinidine Extended-Release
- Metronidazole Extended Release
- Glipizide Extended-Release
- Brompheniramine and Pseudoephedrine Extended Release
email this page
print this page
bookmark this page
feedback on this page
